FDA Roundup: September 27, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-27-2022

Coronavirus (COVID-19) Update: FDA Updates COVID-19 Test Policy, Encourages Developers to Seek Traditional Premarket Review for Most Test Types
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-updates-covid-19-test-policy-encourages-developers-seek-traditional

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-issues-voluntary-nationwide-recall-acyclovir-sodium-injection-500-mg-10-ml-50-mgml-due

FDA Roundup: September 23, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-23-2022

New FDA Draft Guidance Aims to Protect Children who Participate in Clinical Trials
http://www.fda.gov/news-events/press-announcements/new-fda-draft-guidance-aims-protect-children-who-participate-clinical-trials

http://www.fda.gov/medical-devices/medical-device-recalls/philips-respironics-recalls-certain-bipap-machines-plastic-issue-may-expose-patients-certain

http://www.fda.gov/medical-devices/safety-communications/certain-philips-respironics-bipap-machines-recalled-due-plastic-issue-fda-safety-communication

http://www.fda.gov/medical-devices/medical-device-recalls/2022-medical-device-recalls

FDA Roundup: September 20, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-20-2022

FDA Committed to Strengthening U.S. Infant Formula Supply; Review Provides Roadmap to Support Ongoing Efforts
http://www.fda.gov/news-events/press-announcements/fda-committed-strengthening-us-infant-formula-supply-review-provides-roadmap-support-ongoing-efforts